Researchers found that convalescent plasma reduced the need for hospitalization by half for outpatients who participated in the study.
Convalescent plasma is plasma from people who have recovered from COVID-19 and whose blood contains antibodies against SARS-CoV-2, the virus that causes COVID-19.